Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8233750 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
Although our study suggests that there are clinical-pathologic variations for the MamOcc cohort vs. MamPos patients that may ultimately affect management, breast relapse after BCT was not significantly different. Breast recurrences were more often mammographically occult in the MamOcc cohort; consideration should be given to closer follow-up and alternative imaging strategies (ultrasound, breast MRI) for routine posttreatment examination. To our knowledge, this represents the largest series addressing the prognostic significance of MamOcc cancers treated with BCT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tzu-I. J. B.S.R.T.(T)., Qifeng M.D., Ph.D., Bruce G. M.D., Meena S. M.D.,